156 related articles for article (PubMed ID: 24253898)
21. Decrease of let-7f in low-dose metronomic Paclitaxel chemotherapy contributed to upregulation of thrombospondin-1 in breast cancer.
Tao WY; Liang XS; Liu Y; Wang CY; Pang D
Int J Biol Sci; 2015; 11(1):48-58. PubMed ID: 25552929
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of JAK2 Reverses Paclitaxel Resistance in Human Ovarian Cancer Cells.
Xu Y; Zhang J; Wu J; Zhong S; Li H
Int J Gynecol Cancer; 2015 Nov; 25(9):1557-64. PubMed ID: 26360705
[TBL] [Abstract][Full Text] [Related]
23. Anti-proliferative effect of an extract of the root of Polygonum multiflorum Thunb. on MCF-7 human breast cancer cells and the possible mechanisms.
Chen HS; Liu Y; Lin LQ; Zhao JL; Zhang CP; Jin JC; Wang L; Bai MH; Wang YC; Liu M; Shen BZ
Mol Med Rep; 2011; 4(6):1313-9. PubMed ID: 21874249
[TBL] [Abstract][Full Text] [Related]
24. Cyclin-Dependent Kinase 11 (CDK11) Is Required for Ovarian Cancer Cell Growth In Vitro and In Vivo, and Its Inhibition Causes Apoptosis and Sensitizes Cells to Paclitaxel.
Liu X; Gao Y; Shen J; Yang W; Choy E; Mankin H; Hornicek FJ; Duan Z
Mol Cancer Ther; 2016 Jul; 15(7):1691-701. PubMed ID: 27207777
[TBL] [Abstract][Full Text] [Related]
25. Knockdown of the cytoprotective chaperone, clusterin, chemosensitizes human breast cancer cells both in vitro and in vivo.
So A; Sinnemann S; Huntsman D; Fazli L; Gleave M
Mol Cancer Ther; 2005 Dec; 4(12):1837-49. PubMed ID: 16373699
[TBL] [Abstract][Full Text] [Related]
26. LINC00511 knockdown enhances paclitaxel cytotoxicity in breast cancer via regulating miR-29c/CDK6 axis.
Zhang H; Zhao B; Wang X; Zhang F; Yu W
Life Sci; 2019 Jul; 228():135-144. PubMed ID: 31047896
[TBL] [Abstract][Full Text] [Related]
27. Targeting cyclin B1 inhibits proliferation and sensitizes breast cancer cells to taxol.
Androic I; Krämer A; Yan R; Rödel F; Gätje R; Kaufmann M; Strebhardt K; Yuan J
BMC Cancer; 2008 Dec; 8():391. PubMed ID: 19113992
[TBL] [Abstract][Full Text] [Related]
28. Effects of stathmin 1 silencing by siRNA on sensitivity of esophageal cancer cells Eca-109 to paclitaxel.
Zhu HW; Jiang D; Xie ZY; Zhou MH; Sun DY; Zhao YG
Genet Mol Res; 2015 Dec; 14(4):18695-702. PubMed ID: 26782519
[TBL] [Abstract][Full Text] [Related]
29. Paclitaxel suppresses proliferation and induces apoptosis through regulation of ROS and the AKT/MAPK signaling pathway in canine mammary gland tumor cells.
Ren X; Zhao B; Chang H; Xiao M; Wu Y; Liu Y
Mol Med Rep; 2018 Jun; 17(6):8289-8299. PubMed ID: 29658576
[TBL] [Abstract][Full Text] [Related]
30. CyclinG1 Amplification Enhances Aurora Kinase Inhibitor-Induced Polyploid Resistance and Inhibition of Bcl-2 Pathway Reverses the Resistance.
Zhang W; Xu J; Ji D; Li Z; He W; Yang F; Lan H; Wang Y; Wu Z; Liu X; Huang S; Li L; Zhou W
Cell Physiol Biochem; 2017; 43(1):94-107. PubMed ID: 28848145
[TBL] [Abstract][Full Text] [Related]
31. Secretion modification region-derived peptide blocks exosome release and mediates cell cycle arrest in breast cancer cells.
Huang MB; Gonzalez RR; Lillard J; Bond VC
Oncotarget; 2017 Feb; 8(7):11302-11315. PubMed ID: 28076321
[TBL] [Abstract][Full Text] [Related]
32. Let-7g induces granulosa cell apoptosis by targeting MAP3K1 in the porcine ovary.
Cao R; Wu W; Zhou X; Liu K; Li B; Huang X; Zhang Y; Liu H
Int J Biochem Cell Biol; 2015 Nov; 68():148-57. PubMed ID: 26299328
[TBL] [Abstract][Full Text] [Related]
33. [Knockdown of cyclin A2 expression by small interfering RNA in MG-63 cells].
Liu Y; Ding JY; Shen WL; Zhao X; Fan SW
Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):670-5. PubMed ID: 18246796
[TBL] [Abstract][Full Text] [Related]
34. The effects of p38 gene silencing on breast cancer cells.
Doğaner F; Turgut Coşan D; Güneş HV; Değirmenci I; Bal C
Mol Biol Rep; 2014 May; 41(5):2923-7. PubMed ID: 24464183
[TBL] [Abstract][Full Text] [Related]
35. Establishment of paclitaxel-resistant breast cancer cell line and nude mice models, and underlying multidrug resistance mechanisms in vitro and in vivo.
Chen SY; Hu SS; Dong Q; Cai JX; Zhang WP; Sun JY; Wang TT; Xie J; He HR; Xing JF; Lu J; Dong YL
Asian Pac J Cancer Prev; 2013; 14(10):6135-40. PubMed ID: 24289639
[TBL] [Abstract][Full Text] [Related]
36. [Effect of combined use of PDTC and paclitaxel on proliferation and invasion of human breast cancer cell line MCF-7].
Yang C; Zhang H; Huang W; Lin Q; Wei H
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Oct; 27(5):1105-9. PubMed ID: 21089680
[TBL] [Abstract][Full Text] [Related]
37. Silencing MAP3K1 expression inhibits the proliferation of goat hair follicle stem cells.
Ma J; Wang J; Feng Y; Zhang L; Hu H; Wang Q; Chu C; Qu J; Wang Y; Li Y
In Vitro Cell Dev Biol Anim; 2021 Apr; 57(4):428-437. PubMed ID: 33748907
[TBL] [Abstract][Full Text] [Related]
38. Aurora kinase A inhibition and paclitaxel as targeted combination therapy for head and neck squamous cell carcinoma.
Mazumdar A; Henderson YC; El-Naggar AK; Sen S; Clayman GL
Head Neck; 2009 May; 31(5):625-34. PubMed ID: 19107951
[TBL] [Abstract][Full Text] [Related]
39. Rational combinations of siRNAs targeting Plk1 with breast cancer drugs.
Spänkuch B; Kurunci-Csacsko E; Kaufmann M; Strebhardt K
Oncogene; 2007 Aug; 26(39):5793-807. PubMed ID: 17369857
[TBL] [Abstract][Full Text] [Related]
40. Bromodomain‑containing protein 7 sensitizes breast cancer cells to paclitaxel by activating Bcl2‑antagonist/killer protein.
Ma J; Niu W; Wang X; Zhou Y; Wang H; Liu F; Liu Y; Guo J; Xiong W; Zeng Z; Fan S; Li X; Nie X; Li G; Gui R; Luo Y; Zhou M
Oncol Rep; 2019 Mar; 41(3):1487-1496. PubMed ID: 30592293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
